Sofinnova Investments, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$143.31 - $247.0 $6.43 Million - $11.1 Million	44,893 Added 43.57%	147,929 $35.9 Million
Q1 2024 Aug 14, 2024	SELL	$146.51 - $198.2 $6.58 Million - $8.9 Million	-44,893 Reduced 30.35%	103,036 $15.4 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $15.1 Million - $20.4 Million	103,036 New	103,036 $15.4 Million
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $10.2 Million - $13.2 Million	-56,000 Reduced 99.21%	448 $89,000
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $10.5 Million - $13.6 Million	56,448 New	56,448 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $1.97 Million - $2.44 Million	-27,792 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$65.86 - $92.79 $5.19 Million - $7.31 Million	-78,824 Reduced 73.93%	27,792 $2.02 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $7.76 Million - $9.96 Million	106,616 New	106,616 $9.96 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.